Cancer drug safety: time to re-focus on tackling adverse effects.
The Lancet Oncology
D000970:Antineoplastic Agents / Q000009:adverse effects*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000209:etiology*; D006801:Humans; D061214:Patient Safety; D018570:Risk Assessment; D012307:Risk Factors
D000970:Antineoplastic Agents